← Leaderboards
Jianxin Sun
Univ Of Med/Dent Of Nj-Nj Medical School
$8,163,125
Attributed
$9,565,770
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2010–24$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,565,770 · 4
By mechanism
R01$9,565,770 · 4
Top collaborators
- Ross S Summer6 shared
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMediatingIn VivoPreventComplexPlayInflammationBlood VesselsPathologicLipopolysaccharidesAttenuatedVascular DiseasesKnockout MiceEndothelial CellsEndothelial DysfunctionOverexpressionNovel TherapeuticsHypercholesterolemiaMass Spectrum AnalysisInjuryEnzymesDiabetes MellitusPathogenesisPhosphorylation
Grant awards (24)
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$635,918
R01 · FY2024 · HL · contact PI
Prevention of anthracycline-induced cardiotoxicity by Nur77 activation$513,844
R01 · FY2024 · HL · contact PI
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$648,894
R01 · FY2023 · HL · contact PI
Prevention of anthracycline-induced cardiotoxicity by Nur77 activation$524,331
R01 · FY2023 · HL · contact PI
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$106,080
R01 · FY2023 · HL · contact PI
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$648,894
R01 · FY2022 · HL · contact PI
Prevention of anthracycline-induced cardiotoxicity by Nur77 activation$528,278
R01 · FY2022 · HL · contact PI
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$125,970
R01 · FY2022 · HL · contact PI
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury$639,534
R01 · FY2021 · HL · contact PI
Prevention of anthracycline-induced cardiotoxicity by Nur77 activation$526,590
R01 · FY2021 · HL · contact PI
Regulation of Endothelial Nitric Oxide Synthase mRNA Stability$390,000
R01 · FY2020 · HL · contact PI
Nur77 Suppresses Sepsis-Induced Endothelial Dysfunction$296,400
R01 · FY2020 · GM · contact PI
Regulation of Endothelial Nitric Oxide Synthase mRNA Stability$390,000
R01 · FY2019 · HL · contact PI
Nur77 Suppresses Sepsis-Induced Endothelial Dysfunction$296,400
R01 · FY2019 · GM · contact PI
Regulation of Endothelial Nitric Oxide Synthase mRNA Stability$390,000
R01 · FY2018 · HL · contact PI
Nur77 Suppresses Sepsis-Induced Endothelial Dysfunction$296,400
R01 · FY2018 · GM · contact PI
Regulation of Endothelial Nitric Oxide Synthase mRNA Stability$404,000
R01 · FY2017 · HL · contact PI
Nur77 Suppresses Sepsis-Induced Endothelial Dysfunction$296,400
R01 · FY2017 · GM · contact PI
Regulation of Endothelial Nitric Oxide Synthase mRNA stability$381,687
R01 · FY2015 · HL · contact PI
Regulation of Endothelial Nitric Oxide Synthase mRNA stability$379,750
R01 · FY2014 · HL · contact PI
Regulation of Endothelial Nitric Oxide Synthase mRNA stability$368,900
R01 · FY2013 · HL · contact PI
Regulation of Endothelial Nitric Oxide Synthase mRNA stability$387,500
R01 · FY2012 · HL · contact PI
Regulation of Endothelial Nitric Oxide Synthase mRNA stability$387,500
R01 · FY2010 · HL · contact PI
Regulation of Endothelial Nitric Oxide Synthase mRNA stability$2,500
R01 · FY2010 · HL · contact PI